NOVARTIND.NS Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 okt 2023 @ 12:00):

Stats
Dagens volum	11 685.00
Gjennomsnittsvolum	5 696.00
Markedsverdi	16.64B
EPS	INR10.76 ( 2024-02-13 )
Neste inntjeningsdato	( INR0 ) 2024-05-10
Last Dividend	INR37.50 ( 2023-07-20 )
Next Dividend	INR0 ( N/A )
P/E	21.75
ATR14	INR12.22 (1.82%)

Volum Korrelasjon

Lang: 0.74 (moderate)

Kort: 0.00 (neutral)

Signal:(25.341) Neutral

Novartis India Limited Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Novartis India Limited Korrelasjon - Valuta/Råvare

0.33
( neutral )

-0.57
( weak negative )

-0.28
( neutral )

-0.10
( neutral )

-0.85
( strong negative )

-0.49
( neutral )

Novartis India Limited Økonomi

Annual	2022
Omsetning:	INR3.79B
Bruttogevinst:	INR1.77B (46.75 %)
EPS:	INR41.86

FY	2022
Omsetning:	INR3.79B
Bruttogevinst:	INR1.77B (46.75 %)
EPS:	INR41.86

FY	2022
Omsetning:	INR3.88B
Bruttogevinst:	INR2.06B (53.18 %)
EPS:	INR-1.510

FY	2021
Omsetning:	INR3.66B
Bruttogevinst:	INR2.16B (59.07 %)
EPS:	INR8.46

Financial Reports:

No articles found.

Novartis India Limited Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR10.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR37.50 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Novartis India Limited Dividend Information - Dividend Junior

Dividend Sustainability Score: 4.04 - low (34.25%) | Divividend Growth Potential Score: 3.98 - Decrease likely (20.47%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR10.00	2021-08-17
Last Dividend	INR37.50	2023-07-20
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	3	--
Total Paid Out	INR57.50	--
Avg. Dividend % Per Year	2.07%	--
Score	2.56	--
Div. Sustainability Score	4.04
Div.Growth Potential Score	3.98
Div. Directional Score	4.01	--

Next Divdend (Est)
(2024-07-01)

INR65.00 Estimate 3.06 %

Dividend Stability

0.24 Very Poor

Dividend Score

2.56

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2021	INR10.00	1.45%
2022	INR10.00	1.28%
2023	INR37.50	5.57%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SYRMA.NS	No Dividend Player	2023-09-01	Insufficient data to determine frequency	2	0.18%
NEWGEN.NS	Dividend Junior	2023-06-20	Annually	7	2.26%
IFGLEXPOR.NS	Dividend Junior	2023-08-17	Annually	21	1.57%
CHAMBLFERT.NS	Dividend Junior	2023-08-21	Annually	23	1.58%
SAGCEM.NS	Dividend Junior	2023-06-20	Annually	18	0.28%
LTIM.NS	Dividend Knight	2023-07-10	Semi-Annually	9	0.87%
GHCL.NS	Dividend Junior	2023-06-23	Annually	22	1.62%
ARVSMART.NS	No Dividend Player	2023-07-21	Sporadic	6	0.13%
THOMASCOOK.NS	Dividend Junior	2023-08-10	Sporadic	18	0.15%
ORIENTPPR.NS	Dividend Junior	2023-08-01	Annually	18	1.07%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.289	1.500	4.21	6.32	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.129	1.500	9.67	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	70.26	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	2.16	2.00	9.28	10.00	[0 - 30]
freeCashFlowPerShareTTM	2.16	2.00	8.92	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.427	1.000	6.21	6.21	[0.2 - 0.8]
operatingProfitMarginTTM	0.347	1.000	5.06	5.06	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				4.04

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	17.42	1.000	8.34	0	[1 - 100]
returnOnEquityTTM	0.129	2.50	9.79	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	2.16	2.00	9.28	10.00	[0 - 30]
dividendYielPercentageTTM	5.56	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	2.16	2.00	9.28	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.148	1.500	-4.32	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0162	1.000	-2.10	0	[0.1 - 0.5]
Total Score				3.98

Novartis India Limited

Novartis India Limited operates as a healthcare company in India. It offers pharmaceutical products in the areas of bone and pain, calcium portfolio, gynecology, and neurosciences, as well as generics products in the areas of gynecology, anti-TB, and anti-infectives. The company provides central nervous system products under the Tegrital and Exelon brands; pain and inflammation products under the Voveran brand; and transplantation/immunology products under the Simulect, Certican, Myfortic, and Sandimmun Neoral brands. The company was incorporated in 1947 and is headquartered in Mumbai, India. Novartis India Limited is a subsidiary of Novartis AG.